University of Wisconsin–Madison

Contrast Reactions and Pre-Medication

Prophylaxis Policy for Patients Allergic to IV Contrast

What patients require premedication prior to IV contrast?

A prior allergic-like or unknown type reaction to the same class of contrast medium is considered the greatest risk factor for predicting future adverse events. Premedication prior to administration of intravenous contrast is recommended in this group of patients.

In general, patients with unrelated allergies are at a 2- to 3-fold increased risk of an allergic-like contrast reaction, but due to the modest increased risk, restricting contrast medium use or premedicating solely on the basis of unrelated allergies is not recommended. Patients with shellfish or povidone-iodine (e.g., Betadine®) allergies are at no greater risk from iodinated contrast medium than are patients with other allergies (i.e., neither is a significant risk factor).

In patients with reported prior contrast allergy or reaction:

  1. Ascertain the specific details of the prior reaction.  Determine:
    1. If the patient had a true reaction to intravascular contrast material
    2. Type of contrast used (if available)
    3. Type of reaction and severity
    4. Treatment and its result
    5. Level of patient anxiety
  2. In addition to intravascular contrast administration, the following scenarios should be considered in patients with contrast allergy:
    1. Administration of oral contrast.  1-2% of oral contrast could be absorbed.  So for someone who has a severe contrast allergy, they should get dilute barium as an oral contrast agent.  If prior mild reaction and minimum risk of perforation/leak, no need to premedicate.  For moderate reactions or risk of peritoneal leak, consider premedication or dilute barium alternate oral contrast.
    2. Arthrograms.  Because allergic-like reactions are dose-independent, and arthrograms use a needle and cross the bloodstream, use the same premedication strategy for arthrograms that is used for intravenous media. For patients with known contrast allergies, appropriate to premedicate or switch to US if possible.
    3. Hysterosalpingograms: In patients with patent fallopian tubes, there is peritoneal spill of contrast.  Intraperitoneal contrast is absorbed (intraperitoneal=intravascular).  Because of the dose independence, premedication for HSGs should be performed in patients with known contrast allergies.
  3. Determine if an examination without contrast can provide adequate diagnostic information.
  4. If still convinced of the need for intravascular contrast, the service requesting  the scan should:
    1. Contact the radiologist scheduled on service for the proposed date of the study (GI/GU, CT, Angiography, Neuroradiology, or on-call resident for overnight/weekend Emergency Department patients).  If the staffing schedule is not available for the proposed date of the examination, then the Chief of the GI/GU Service (Dr. Perry Pickhardt), CT Service (Dr. Meghan Lubner), Angiography/Interventional Service (Dr. Orhan Ozkan), or Neuroradiology Service (consultant for the day) should be contracted.
    2. Discuss why an alternative imaging method will not suffice
    3. If the risk is determined to be acceptable; schedule the contrast examination and transmit prophylaxis instructions.
  5. Routine Contrast Reaction Prophylaxis (12 hour):
    1. Methylprednisolone (Medrol)
      1.  32 mg by mouth at 12 and 2 hours before contrast injection.
    2. Diphenhydramine (Benadryl):
      1. 50 mg intramuscular or oral 1 hour before contrast injection OR
      2. 50 mg (or 25 mg per height/weight indication) intravenously 15-20 min before contrast injection
        Note:  The Benadryl must be used with the proviso that the patient does not drive a car or operate heavy machinery 4-6 hours after the Benadryl is administered.
        NEJM 1987; 317: 845-849.
    3. If a patient is unable to take oral medication, consider the 5 hr regimen detailed in #6.  Alternatively the methylprednisolone may be substituted with 200 mg hydrocortisone IV at 13, 7, and 1 hour before contrast administration. If a patient is allergic to diphenhydramine in a situation where diphenhydramine would otherwise be considered, an alternate anti-histamine without cross-reactivity may be considered, or the anti-histamine portion of the regimen may be dropped.
  6. Rapid Contrast Reaction Prophylaxis (5 hours):
    1. To be used only in a truly urgent situation after discussion between the requesting service and the appropriate radiology service.
    2. The requesting service must place a note in HealthLink outlining the necessity of contrast-enhanced examination and the rapid prohpylaxis protocol.
    3. Hydrocortisone:
      1. 200 mg intravenously 5 and 1 hour before contrast injection
    4. Diphenhydramine (Benadryl):
      1. 50 mg intravenously 1 hour before contrast injection
  7. In addition to steroid premedication, changing the culprit iodinated agent if known may decrease the risk of repeat allergic reaction. Consider substitution of an iso-osmolar agent (iodixanol) if a low osmolar agent was previously administered.

Greenberger PA et al. Emergency administration of radiocontrast media in high-risk patients. J Allergy CLin Immunol. 1986; 77(4): 630-634.

Resources

  • Mervak BM, Cohan RH, Ellis JH, Khalatbari S, Davenport MS.  Premedication administered 5 hours before CT compared with a Traditional 13-hour Oral regimen. Radiology 2017; 285(2), 425-433.
  • McDonald JS, Larson NB, Kolbe AB et al. Prevention of Allergic-like Reactions at Repeat CT: Steroid Pretreatment versus Contrast Material Substitution. Radiology 2021; 000:1-8.

Updated July 2020

Pre-medication Policy for Patients Receiving Chronic Corticosteroid Therapy

Purpose

This document provides guidance for technologists and physicians managing patients who require corticosteroid premedication for a prior contrast allergy and who are already receiving corticosteroid therapy for another clinical indication.

This guidance is based on recommendations from the American College of Radiology (ACR) Manual on Contrast Media and supporting endocrine literature. Clinical management should be individualized based on patient-specific factors.

Background

The ACR Manual on Contrast Media provides general guidance for premedication in patients receiving chronic corticosteroid therapy. While the manual notes that premedication dosing “may be modified” in these patients, there is limited evidence supporting specific dosing adjustments.

General Principles:

  • Patients receiving only Physiologic (Replacement) corticosteroid dosing generally do not require adjustment to standard premedication dosing.
  • Patients already receiving Supraphysiologic (Therapeutic) corticosteroid dosing may require adjustment of the standard premedication regimen.

Corticosteroid Dose Categories

Approximate Physiologic Daily Dose
Corticosteroid
Approximate Physiologic Daily Dose
Hydrocortisone15–25 mg/day
Prednisone / Prednisolone4–6 mg/day
Methylprednisolone3–5 mg/day
Dexamethasone0.25–0.5 mg/day
  • Supraphysiologic (Therapeutic) Corticosteroid Dosing
    • Any corticosteroid dose above physiologic replacement levels is considered therapeutic or supraphysiologic dosing.

Guidance for Premedication Adjustment

Patients on Physiologic (Replacement) Dose Steroids

(Doses equal to or below hydrocortisone 15-25 mg per day, or equivalent)

  • No dose adjustments to premedication corticosteroids are made

Patients on Supraphysiologic (Therapeutic) Dose Steroids

(Doses equal to or below hydrocortisone 15-25 mg per day, or equivalent)

  • Providers may consider reducing the total premedication corticosteroid dose by an
    amount equivalent to the patient’s baseline daily corticosteroid dose.
  • Adjustments should be individualized based on clinical judgment, patient condition,
    and risk assessment.

Delayed Imaging

If imaging is delayed after initiation of corticosteroid premedication:

  • Patients should ideally receive at least 4–5 hours of corticosteroid therapy prior to contrast administration.
  • Repeat corticosteroid doses may be administered every 4–8 hours until contrast exposure, when clinically appropriate.

Additional Risk Reduction Strategies

Premedication alone does not eliminate the risk of contrast reaction. Additional strategies should be considered whenever feasible, including:

  • Using an alternative contrast agent within the same class
  • Selecting a different contrast class when appropriate (e.g., iodinated contrast, gadoliniumbased contrast, or barium)
  • Reviewing prior reaction history and severity
  • Considering non-contrast imaging alternatives when clinically appropriate

Switching contrast agents may, in some cases, be more effective than premedication alone in reducing the likelihood of a repeat reaction.

Resources

  1. Abe S, Fukuda H, Tobe K, Ibukuro K. Protective effect against repeat adverse reactions to iodinated contrast medium: Premedication vs. changing the contrast medium. Eur Radiol. 2016;26(7):2148-2154. doi:10.1007/s00330-015-4028-1
  2. Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency. J Clin Endocrinol Metab. 2024;109(7):1657-1683. doi:10.1210/clinem/dgae250
  3. Husebye ES, Pearce SH, Krone NP, Kämpe O. Adrenal insufficiency. Lancet. 2021;397(10274):613-629. doi:10.1016/S0140-6736(21)00136-7
  4. Park HJ, Park JW, Yang MS, et al. Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: A multicentre retrospective cohort study. Eur Radiol. 2017;27(7):2886-2893. doi:10.1007/s00330-016-4682-y
  5. ACR Manual on Contrast Media. American College of Radiology. Updated 2025. Accessed March 31, 2026. https://www.acr.org/clinical-resources/clinical-tools-andreference/contrast-manual.

Updated April 2026

EpiPen Tutorial – Giuseppe Toia, MD

Contrast Reactions and Pre-Medication